Krystal Biotech, Inc. Current Assets
Krystal Biotech, Inc. (KRYS) had Current Assets of $1.06 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-03
- 2026-06-30: Assets, Current $1.06B.
- 2026-03-31: Assets, Current $1.02B.
- 2025-12-31: Assets, Current $1.02B.
- 2025-09-30: Assets, Current $925.65M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $1.06B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.02B 10-Q · filed 2026-05-04 |
| 2025-12-31 | $1.02B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $925.65M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $841.35M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $766.80M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $742.04M 10-K · filed 2026-02-17 |
| 2024-09-30 | $713.16M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $682.77M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $602.25M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $587.91M 10-K · filed 2025-02-19 |
| 2023-09-30 | $582.13M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $484.00M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $355.43M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $383.78M 10-K · filed 2024-02-26 |
| 2022-09-30 | $397.58M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $428.77M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $438.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $442.27M 10-K · filed 2023-02-27 |
| 2021-09-30 | $345.81M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $369.93M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $405.83M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $275.06M 10-K · filed 2022-02-28 |
| 2020-09-30 | $287.65M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $298.54M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $188.33M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $195.88M 10-K · filed 2021-03-01 |
| 2019-09-30 | $204.44M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $196.20M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $107.89M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $112.65M 10-K · filed 2020-03-10 |
| 2018-09-30 | $52.82M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $45.71M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $47.67M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $49.91M 10-Q · filed 2018-11-05 |
| 2017-09-30 | $52.62M 10-Q · filed 2017-11-13 |
| 2016-12-31 | $2.17M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |